Skip to main content

Therma Bright Inc(THRM-X)
TSX Venture

Today's Change
Delayed Last Update
Day Low0.055
Day High0.060
Open:0.060
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

Top Stories: Therma Bright Inc

Select a category then submit the form to load news
Newsfile
Therma Bright Portfolio Update: Inretio Successfully Completes First-in-Human Cohort for PREVA(TM) Stroke Platform; Targets 2026 U.S. FDA Trial
Newsfile
Therma Bright Sells an Additional 200-Units of Venowave(TM) to Strategic Distribution Partner Gen-X Med
Newsfile
Therma Bright Inc. Investee Company, InStatin Expands its Inhaled Statin Programs to include COPD (Chronic Obstructive Pulmonary Disease) as its Lead Indication.
Newsfile
Therma Bright Appoints US Healthcare Veteran Michael Raimondo to the Board of Directors
AI-generated - The Globe and Mail
Therma Bright: Top 10 Undervalued Medical Devices & Instruments Industry Stocks (THRM)
Newsfile
Therma Bright Expands Relationship with Distribution Partner Gen-X Med for Venowave(TM) Sales
Newsfile
Therma Bright Proposes to Amend Certain Warrants
AI-generated - The Globe and Mail
Therma Bright: Top 10 Undervalued Medical Devices & Instruments Industry Stocks (THRM)
Newsfile
Therma Bright Announces Share Consolidation
AI-generated - The Globe and Mail
Therma Bright: Top 10 Undervalued Medical Devices & Instruments Industry Stocks (THRM)
Newsfile
Therma Bright Inc. Announces Share Consolidation
Newsfile
Therma Bright Proposes to Amend Certain Warrants and Negotiates Debt Settlements
AI-generated - The Globe and Mail
Therma Bright: Top 10 Undervalued Medical Devices & Instruments Industry Stocks (THRM)
Newsfile
Therma Bright Inc. Provides Update on InStatin Development, Announcement of Key Strategic Advisor and Highlights Preclinical and IP Progress at InStatin
Newsfile
Therma Bright Secures New Customer Initial Purchase Order, Signaling Market Confidence
AI-generated - The Globe and Mail
Therma Bright: Top 10 Undervalued Medical Devices & Instruments Industry Stocks (THRM)
Newsfile
Therma Bright Reviews Manufacturing Strategy in Light of US Tariff Changes
TheNewswire.com
Image Protect Announces New Consumer Products Division and Secures Exclusive Marketing and Distribution Rights for Major Health-Related Products in Multi-Billion Dollar Sectors
Newsfile
Therma Bright Secures an Initial Limited Exclusive U.S. Marketing and Distribution Contract for Its Consumer Products with Global Wellness Products LLC
Newsfile
Therma Bright Welcomes Healthcare and Technology Expert Steve Raysely to its Advisory Board
AI-generated - The Globe and Mail
Therma Bright: Top 10 Undervalued Medical Devices & Instruments Industry Stocks (THRM)
Newsfile
Therma Bright Secures Purchase Order For 1,750 Venowave W5 Units From National Distributor - DME Authority of Nashville, TN
Newsfile
Therma Bright Secures Purchase Order For Initial 100 Venowave Units From New National Distribution Partner - Valor Medical of San Antonio
Newsfile
Therma Bright Announces Shares for Debt Issuance
Newsfile
Therma Bright Announces Shares for Debt Issuance
Newsfile
Therma Bright Signs LOI For U.S. Distribution Network Expansion For Venowave With DME Authority
Newsfile
Therma Bright Congratulates Investment Partner Inretio's Promising Initial Results from PREVA(TM) Device's First Clinical Phase
Newsfile
Therma Bright's Distribution Partners Achieve 100% HCPCS Code Reimbursement In Under 60 Days
AI-generated - The Globe and Mail
Therma Bright: Top 10 Undervalued Medical Devices & Instruments Industry Stocks (THRM)
Newsfile
Therma Bright to Spin Off Consumer Product Portfolio to Create Two Publicly Traded Companies
Newsfile
Therma Bright Announces Shares for Debt Issuance
Newsfile
Therma Bright's Investment Partnership InStatin Joins Forces with InVixa to Enhance Its Patent Portfolio For The Development Of Innovative Respiratory Solutions

Profile

Therma Bright Inc is a developer and partner in a range of proprietary diagnostic and medical device technologies focused on providing consumers and medical professionals with solutions to address important medical and healthcare challenges. The Company is developing, acquiring, manufacturing and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace focused on 3 key strategic areas: respiratory disease, vascular health, and consumer medical devices.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.